Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 2 (4)

The Impact of Allograft CXCL9 During Respiratory Infection on the Risk of Chronic Lung Allograft Dysfunction


The Impact of Allograft CXCL9 During Respiratory Infection on the Risk of Chronic Lung Allograft Dysfunction

Michael Y Shino et al. OBM Transplant.


Background: The long term clinical significance of respiratory infections after lung transplantation remains uncertain.

Methods: In this retrospective single-center cohort study of 441 lung transplant recipients, we formally evaluate the association between respiratory infection and chronic lung allograft dysfunction (CLAD). We furthermore hypothesized that bronchoalveolar lavage fluid (BALF) CXCL9 concentrations are augmented during respiratory infections, and that episodes of infection with elevated BALF CXCL9 are associated with greater CLAD risk.

Results: In univariable and multivariable models adjusted for other histopathologic injury patterns, respiratory infection, regardless of the causative organism, was a strong predictor of CLAD development (adjusted HR 1.8 95% CI 1.3-2.6). Elevated BALF CXCL9 concentrations during respiratory infections markedly increased CLAD risk in a dose-response manner. An episode of respiratory infection with CXCL9 concentrations greater than the 25th, 50th, and 75th percentile had adjusted HRs for CLAD of 1.8 (95% CI 1.1-2.8), 2.4 (95% CI 1.4-4.0) and 4.4 (95% CI 2.4-8.0), respectively.

Conclusions: Thus, we demonstrate that respiratory infections, regardless of the causative organism, are strong predictors of CLAD development. We furthermore demonstrate for the first time, the prognostic importance of BALF CXCL9 concentrations during respiratory infections on the risk of subsequent CLAD development.

Keywords: CXCL9; CXCR3; Lung transplantation; chronic lung allograft dysfunction; infection.

Conflict of interest statement

Competing Interests The authors have declared that no competing interests exist.


Figure 1
Figure 1
Definition of abbreviations: ALI = acute lung injury, OP = organizing pneumonia, LB = lymphocytic bronchiolitis, AR = acute rejection

Similar articles

See all similar articles


    1. Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dobbels F, Kirk R, et al. The registry of the international society for heart and lung transplantation: Twenty-eighth adult lung and heart-lung transplant report−−2011. J Heart Lung Transplant. 2011; 30: 1104–1122. - PubMed
    1. Allyn PR, Duffy EL, Humphries RM, Injean P, Weigt SS, Saggar R, et al. Graft loss and CLAD-onset is hastened by viral pneumonia after lung transplantation. Transplantation. 2016; 100: 2424–2431. - PMC - PubMed
    1. Billings JL, Hertz MI, Savik K, Wendt CH. Respiratory viruses and chronic rejection in lung transplant recipients. J Heart Lung Transplant. 2002; 21: 559–566. - PubMed
    1. Fisher CE, Mohanakumar T, Limaye AP. Respiratory virus infections and chronic lung allograft dysfunction: Assessment of virology determinants. J Heart Lung Transplant. 2016; 35: 946–947. - PubMed
    1. Khalifah AP, Hachem RR, Chakinala MM, Schechtman KB, Patterson GA, Schuster DP, et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med. 2004; 170: 181–187. - PubMed